This is when your body doesn't have enough of a special protein called Protein C. Protein C helps control how your blood clots. Not having enough of it can make you more likely to get blood clots, which can be dangerous.
Every report comes from a Lived member, sent anonymously.
Have you tried Coumadin (Warfarin) for Protein C Deficiency?
Protein C deficiency is a condition in which the blood does not have enough working protein C, one of the body's natural anticlotting proteins. Protein C normally switches off certain clotting proteins once a clot has done its job. When there is too little of it, or it does not work properly, blood can clot more easily than it should, inside veins where no clot is needed. Most people have the mild form, which is inherited and fairly common. It raises the chance of a deep vein thrombosis (DVT), a clot in a deep vein of the leg or arm, which can break loose and travel to the lungs as a pulmonary embolism (PE). Clots can also form at a younger age than usual or in unusual places, such as the veins of the abdomen. A severe form is very rare and appears in newborns as purpura fulminans: widespread clotting in small blood vessels that causes dark purple patches on the skin and can damage tissue. It is life-threatening and needs specialist care from birth.
The inherited form comes from a change in the PROC gene, which carries the instructions for making protein C. Inheriting one altered copy from either parent causes the mild form; estimates suggest it affects roughly 1 in 250 to 1 in 500 people. Inheriting altered copies from both parents causes the severe form, which occurs in about 1 in 4 million newborns. Because one copy is enough, each child of a parent with the mild form has a 1 in 2 chance of inheriting it. Having the gene change raises risk but does not make a clot inevitable. Most people with the mild form never have an abnormal clot. Clots tend to appear when other pressures add up: surgery, a long hospital stay or other inactivity, pregnancy and the weeks after birth, estrogen-containing birth control or hormone therapy, and older age. Carrying a second inherited clotting condition, such as factor V Leiden, adds further risk. Protein C can also be low without an inherited cause. Warfarin, liver disease, chemotherapy, long-term antibiotic use, severe infection with widespread clotting (disseminated intravascular coagulation) and a recent large clot can all lower the level for a time.
Protein C deficiency is diagnosed with blood tests, usually after someone has had a clot at a young age, a clot without an obvious cause, a clot in an unusual place, or a close relative with a known deficiency. The main test measures protein C activity, meaning how well the protein actually works. Results are reported as a percentage of normal, with the expected range set by each lab. A second test of the amount of protein C helps separate type I (too little protein) from type II (enough protein that does not work properly). Timing matters because many things lower protein C temporarily. A level drawn during an acute clot, while taking warfarin, or with liver disease can look like an inherited deficiency when it is not. Specialists usually wait until the first months of treatment are finished, allow about two weeks off warfarin or a few days off a newer blood thinner when that is safe, and repeat a low result before giving a diagnosis. Genetic testing of the PROC gene is sometimes used to confirm the cause or to test family members. Testing relatives is most useful when the result would change a decision, such as whether to avoid estrogen-containing birth control or hormone therapy, or whether to use clot prevention during surgery, pregnancy or another higher-risk period.
Treatment aims to treat clots when they happen and to prevent new ones at the times they are most likely. A clot is treated with blood thinners (anticoagulants), medicines that stop clots from growing and lower the chance of another while the body breaks the existing one down. Options include heparin injections, warfarin tablets, and newer direct oral anticoagulants (DOACs), which need no routine blood monitoring. How long treatment continues depends on what triggered the clot, whether it has happened before and the person's bleeding risk; some people stop after about three months, while others stay on a blood thinner long term. Warfarin needs particular care in this condition. Warfarin also lowers protein C, and in the first days of treatment this can briefly make clotting worse and, rarely, cause areas of skin to die (warfarin-induced skin necrosis). For this reason, people with protein C deficiency are usually given heparin first and kept on it until warfarin has fully taken effect. People with the mild form who have never had a clot usually do not take a blood thinner every day, because their yearly risk, roughly 1 in 100 in family studies, does not outweigh the bleeding risk of continuous treatment. Instead, protection is focused on higher-risk periods, such as preventive injections after surgery, during a hospital stay or around pregnancy. Low-molecular-weight heparin is preferred in pregnancy because it does not cross the placenta, while warfarin can harm the developing baby. Many people with the deficiency are advised to choose birth control without estrogen. The severe newborn form is treated with protein C concentrate (Ceprotin), a medicine made from donated human plasma that replaces the missing protein. It is used to treat and prevent purpura fulminans and clots, under the care of a hematologist, a doctor who specializes in blood disorders.
For most people with the mild form, daily life is unaffected. Many learn they have it only after a relative is diagnosed, and many never have a clot. The practical change is planning ahead: telling every surgeon, obstetrician and prescriber about the diagnosis, discussing clot prevention before operations, long hospital stays or pregnancy, keeping active and moving regularly on long trips, and choosing contraception and hormone treatments with clot risk in mind. After a clot, the outlook with treatment is usually good, but clots can come back, especially once a blood thinner is stopped. Regular check-ins with the care team review whether to continue anticoagulation as circumstances change. Anyone taking warfarin needs regular INR (international normalized ratio) blood tests, which show how long the blood takes to clot, to keep the dose in a safe range. The severe form is a lifelong condition that needs ongoing specialist care, because purpura fulminans can return after the newborn period. Families work closely with a hematology team on replacement therapy and blood thinners.
Ask about protein C testing if you have had a clot at a young age, a clot with no clear cause, or a clot in an unusual place, or if a close relative has protein C deficiency, especially before surgery, pregnancy or starting estrogen-containing birth control or hormone therapy. Call your care team right away if one leg or arm becomes swollen, painful, warm or red, since these can be signs of a deep vein thrombosis. Call 911 or go to the emergency room for sudden shortness of breath, chest pain that worsens with breathing, coughing up blood, or fainting, which can signal a pulmonary embolism.
Last reviewed • Oct 2026
Educational content, not medical advice.
Has anyone else had to go on Lovenox- I have been on 20 years now and just wish I could find a pill that would work for me.